NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/25/2022
Back to search
Official data from USPTO
CYTEMOUNT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
05/25/2022
Trademark type
Word
Nice classes
5
Filing date
05/17/2018
Registration date
05/24/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/24/2022
Last transaction
05/24/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/29/2019
First use in commerce
07/29/2019
Drawing code
4
Owner type
03
Owner location
Seattle, WA
Examiner
COLLIER, DAVID
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
RareCyte, Inc.
Representatives
Gabrielle A. Holley HOLLEY & MENKER, P.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations for pharmaceutical or medical purposesfor use in the analysis of biological samples for the diagnosis and treatment of cancerfetalrare cellhematological disorders
Publications
History of USPTO decisions and trademark events.
37 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/21/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/20/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/12/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/14/2022
IUAF
USE AMENDMENT FILED
12/07/2021
EISU
TEAS STATEMENT OF USE RECEIVED
12/07/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/25/2021
EX5G
SOU EXTENSION 5 GRANTED
05/24/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/24/2021
EXT5
SOU EXTENSION 5 FILED
05/17/2021
EEXT
SOU TEAS EXTENSION RECEIVED
05/17/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/26/2020
EX4G
SOU EXTENSION 4 GRANTED
11/24/2020
EXT4
SOU EXTENSION 4 FILED
11/24/2020
EEXT
SOU TEAS EXTENSION RECEIVED
11/24/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/16/2020
EX3G
SOU EXTENSION 3 GRANTED
05/14/2020
EXT3
SOU EXTENSION 3 FILED
05/14/2020
EEXT
SOU TEAS EXTENSION RECEIVED
05/14/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/07/2019
EX2G
SOU EXTENSION 2 GRANTED
12/05/2019
EXT2
SOU EXTENSION 2 FILED
12/05/2019
EEXT
SOU TEAS EXTENSION RECEIVED
12/05/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/07/2019
EX1G
SOU EXTENSION 1 GRANTED
06/05/2019
EXT1
SOU EXTENSION 1 FILED
06/05/2019
EEXT
SOU TEAS EXTENSION RECEIVED
06/05/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/11/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/16/2018
PUBO
PUBLISHED FOR OPPOSITION
10/16/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/26/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2018
DOCK
ASSIGNED TO EXAMINER
09/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/25/2018
NWAP
NEW APPLICATION ENTERED
05/21/2018
Continuous trademark protection
Get notified about every new filing that threatens CYTEMOUNT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.